N/A N=72 Randomized Single-blind Prevention

Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass

Coronary Bypass Graft Stenosis of Autologous Vein

Bottom Line

View on ClinicalTrials.gov: NCT02010996 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2014

Primary outcome: Primary: Early Complications of Vascular Zone — 1; 4; 15; 5 participants — p=0.05

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: vacuum assisted closure (Procedure); Axillary dissection (Procedure)
Age: Pediatric, Adult, Older Adult · 10+ yrs
Sex: All
Sponsor: Changhai Hospital
Primary completion: Apr 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Early Complications of Vascular Zone	1; 4; 15; 5	0.05

Summary

The great saphenous vein is the most commonly used material in coronary vascular bridging operation. Coronary bypass operation to obtain the great saphenous vein is mainly through the incision open groin to ankle. This operation may damage the lymphatic, cause lymph circumfluence obstacle, cause fat liquefaction, scar formation, wound dehiscence, around hematoma and other a series of symptoms.Based on some studies and our experience that vacuum assisted closure （VAC）is effective in complex wound failures following Stripping saphenous vein, we use VAC to prevent seroma formation after Stripping saphenous vein in Coronary bypass. This study is aimed to evaluate the efficacy and economics benefits of early VAC application on postoperative complications and wound healing after Stripping saphenous vein in Coronary bypass in comparison to conventional suction drain.

Eligibility Criteria

Inclusion Criteria

Written informed consent
Coronary heart disease patients to transplant more than 2 vascular bridge
The thigh groin following from the saphenous vein

Exclusion Criteria

Subjects does not agree to participate in clinical trials
Subjects had a injury, operation history of Thigh
Subjects having ever received chemotherapy before the surgery
Subjects with known hypersensitivity to components of the surgical sticky membrane

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02010996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.